Buy Otonomy Stock | OTIC Stock Price & Latest News | Public.com
OTIC

Otonomy

$0.00 (0.00%)Today
    Small Market Cap
    View Otonomy (OTIC) stock trends here

    About OTIC

    Otonomy, Inc. operates as a biopharmaceutical company. It engages in the development of therapeutics for neurotology. The firm’s product pipeline includes OTIVIDEX (dexamethasone) Meniere's disease, OTIPRIO (ciprofloxacin otic suspension) acute otitis media with tubes (...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.12
    -0.25
    -0.37
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.25

    Actual EPS
    Q1 2021

    Stats

    Market Cap$144,95M
    Volume1,19M
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$6.98
    1 Year Low$1.53
    Open$2.89
    High$3.14
    Low$2.78

    Buy any stock with any amount of money.

    Download the App
    Download the app